[Cardiac effects of glucagon-like peptide 1].
Jens Juul
JJ
Holst
D002319:Cardiovascular System / Q000187:drug effects*; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D000069450:Liraglutide; D010455:Peptides / Q000494:pharmacology; D018027:Receptors, Glucagon / Q000187:drug effects / Q000378:metabolism; D012307:Risk Factors; D014688:Venoms / Q000494:pharmacology
C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide